1158th: Difficult Game

In fact, Xiao Feng brought He Fangzhou to the reception this time for another purpose.

That is to meet and discuss business with representatives of some of the largest pharmaceutical companies in the world.

These pharmaceutical factories are now He Fangzhou's licking dogs, or in other words, they all ask for He Fangzhou.

And Xiao Feng thinks that this is a very good time to negotiate with them.

Any one of these pharmaceutical companies is well-known internationally. Roche, AstraZeneca, Bayer, Novartis Switzerland, Johnson & Johnson, Pfizer, etc. have all come.

In the past, even if Xiao Feng wanted to meet so many representatives at once, it would not have been so easy.

After all, if one of these giants in the medical industry is chosen at random, their net worth is not much lower than that of Xiao Feng.

So it is not so easy to meet with them, or even start a negotiation.

Vogelin, who was under Xiao Feng's name, had contacted them several times.

However, the progress of the negotiations can be said not to be particularly smooth.

In addition to some pharmaceutical companies that have cooperated with them, such as Pfizer and Johnson & Johnson in the United States, the other Swiss and German pharmaceutical companies are not so easy to talk to.

The reason why Voegelin contacted them was naturally to hope to obtain the prescription agency rights of some of their exclusive drugs.

In the past, Vogreens had more than 9,000 stores at its peak, while their competitor, CVS, had more than 12,000 chain stores in the United States.

But at that time, Vogelin was still able to surpass CVS and become the No. 1 chain drugstore industry in the United States.

It relies on two aspects. On the one hand, Voegelin is mainly rooted in wealthy areas in the United States where there are more middle-class and wealthy people, where consumers have relatively strong spending power.

On the other hand, it is because Voegelin holds the right to prescribe a large number of drugs.

The medical system in the United States is different from that in China. They are patients who go to the hospital to see a doctor, and then the doctor writes a prescription.

Patients take prescriptions and go to pharmacies outside to buy medicines. The hospital does not sell medicines except during operations and first aid.

This will ensure that the operation of the hospital is more 'clean'.

Most of the medicines sold in pharmacies are prescription medicines.

These drugs are often specific to certain diseases, relatively broad.

And as a chain pharmacy, whoever masters can prescribe more medicines will naturally occupy more markets.

And Voegelin undoubtedly did the best in this regard a few years ago.

At the peak, they once occupied 31% of the prescription drug sales rights in the US market.

However, in recent years, as the patents of many prescription drugs in their hands have expired, various generic drugs have begun to seize the market.

And because of the debt crisis, their cooperation with many pharmaceutical companies was also terminated early.

This caused them to lose a lot of prescription drug rights when Xiao Feng took over Voegelin.

The prescription drugs on the market that they have mastered have dropped to 19%.

On the contrary, their opponent CVS, at this time, has the right to prescribe drugs, which has risen to 27%.

However, after Xiao Feng took over the Voegelin drugstore chain, with the authorization of the Ninth Laboratory.

Voegelin has become the only chain pharmacy in the United States that can officially sell the cosmetics and health care products of the Ninth Laboratory.

This has brought a huge flow of people to Voegelin, and Juice King Coffee, which is now very popular in the United States, has also joined Voegelin's chain.

All these have brought huge flow to Voegelin. With these flows, Voegelin's cash flow has improved significantly.

Moreover, Xiao Feng had already helped them repay most of the bank's debts.

So Voegelin has only changed hands for three months, and their latest quarterly financial report shows that they have begun to turn losses into profits.

And now Voegelin's 'boss' Helen also participated in this meeting.

Attending the conference were not only representatives from Xiao Feng and Voegelin, but also representatives from the Huaguo Neptune drugstore chain.

That's why Xiao Feng greeted Mr. Wan and asked him to give him a ride.

In fact, Mr. Wan originally advocated the acquisition of Voegelin, and the reason why he wanted to acquire Voegelin.

In fact, they want to contact those pharmaceutical companies through Vogelin, and then get some cheap medicines from these world giants.

And after getting these specific medicines for certain diseases, their Neptune Pharmacy can quickly build a reputation and gain a firm foothold in the market.

Otherwise, it would be really difficult for a chain pharmacy to win the competition.

In the domestic chain pharmacy industry, except for the National University with a state-owned background, other chain pharmacies are basically local in nature.

In the same province, or even in the same city, there will be a chain pharmacy with its own brand.

It is really too difficult for a chain drugstore with private capital to open all over the country.

On the one hand, it is because of local protection policies, and on the other hand, it is because of the channels for drug purchases.

Many local pharmacies are actually behind local pharmaceutical factories.

The reason why Wan Gongzi's Neptune can be opened all over the country is because of their family's previous real estate business.

Their family's commercial real estate is already a famous brand in the real estate industry.

This provides him with a place to open a store, and he never worries about lack of traffic.

In this way, he can easily open chain drugstores all over the country, but opening a store is opening a store. If you want to gain a firm foothold in the fierce competition, that is the time to really test your skills.

For this reason, Mr. Wan also purchased several pharmaceutical factories to produce broad-spectrum drugs for his own chain drugstores.

One is to avoid being stuck by the pharmaceutical factory, and the other is to reduce costs.

But even so, his Neptune Pharmacy still doesn't have much advantage.

In this way, he turned his idea to the specific drugs sold by many foreign pharmaceutical companies.

These drugs, such as Iressa, a special drug developed by EstraZeneca in the United Kingdom, are specifically for lung cancer.

The global sales of this drug totaled about 10 billion last year, and country H contributed 20% of the market, about 2 billion.

The damn thing is that a 250 mg preparation of this drug costs only 10.3 US dollars in the United States, but in country H, it costs 500 yuan in soft sister coins.

There is also Tarceva, a commonly used drug for renal cell carcinoma produced by Roche Pharmaceuticals, which is priced at 600 yuan a tablet in the United States, but it is as high as 650 yuan in China.

This is fair, the most fucked up drugs are the drugs of European pharmaceutical companies.

For example, Nexavar, a special drug for leukemia developed by Bayer, costs 60 yuan a tablet in the United States, but it costs as much as 400 yuan in China.

It's like slaughtering Huaguo patients as pigs.

There is also Herceptin, a special drug for breast cancer, which sells for 12,500 pieces in the United States, but in China the price is as high as 25,000.

Xiao Feng is also speechless at this price, who will let the domestic pharmaceutical companies not live up to it.

Even if you want to negotiate with others, you are not qualified.

Previously, Neptune Pharmacy had reached a strategic partnership with Voegelin.

So they can buy these specific medicines through Voegelin's channels.

Buy it at the price in the United States, plus some shipping fees, customs duties, etc., and bring it back to China for sale.

The price is indeed much lower than domestic sales, which has indeed benefited many patients.

But even so, the price is still very expensive, such as the specific medicine for leukemia.

The price is still very expensive now, and the most leukemia patients in China are children.

Seeing this situation, Xiao Feng was very worried.

So he thought, through this reception, all the representatives of these pharmaceutical companies will be gathered together, and then the prices of these drugs will be lowered.

In the past, he would never have dared to think like this.

Because he doesn't have the capital to negotiate with these pharmaceutical companies, although his ninth laboratory is doing very well now.

However, several signature products of the Ninth Laboratory did not pose much threat to the opponent at all.

So he does not have a decent bargaining chip to negotiate with the other party.

But now with He Fangzhou, the representative of the new era of surgery and medical care, he has a bargaining chip to negotiate with the other party.

Don't you have special medicine?

Then please lower the price for me, such as Iressa, you are targeting lung cancer, right?

If you don't lower the price, then I will directly develop artificial lungs. If anyone gets lung cancer in the future, we will directly replace his lungs.

You don't even have to buy medicine if you want to.

There is also Tarceva for renal cell carcinoma, please quickly lower the price for me, otherwise I will immediately put the artificial kidney on the market, and your medicine will not be available for purchase at that time.

And the Duojimei produced by Bayer's bastards, you should also quickly lower the price for me.

Xiao Feng especially didn't enjoy watching the Germans, and he didn't know why there were so many German bragging in China.

When he was young, he also had a good impression of Germany.

But later I saw too many German companies consuming the feelings of Chinese people.

For example, Volkswagen's car cuts corners, Mercedes-Benz's car steals materials, broken axles, etc.

You see, they were fined billions of dollars in the United States for cheating exhaust emissions, and they didn't even dare to fart.

But when something happened in Huaguo, they didn't take Huaguo consumers seriously at all, and instead repeatedly consumed the feelings of Huaguo consumers.

So Xiao Feng wondered why there are so many virtues in the country.

His sense of Germany is really not very good, which can be seen from the drug Nexavar.

I bought 60 in the United States, but bought 400 in Huaguo. I can't bear it.

Therefore, Xiao Feng's request to them at this meeting is also to lower the price.

Otherwise, he will organize He Fangzhou to develop artificial bone marrow as soon as possible, so that they will not be able to buy their medicine when the time comes.

This is destined to be a difficult game, after all, these foreign pharmaceutical companies are not intimidated.

Moreover, this is a matter that directly endangers their economic interests, so the negotiation has just begun, and it has become a pot of porridge.

Neither side was willing to give in easily, especially those pharmaceutical companies, who were even more furious after learning of Xiao Feng's intention to come.

The scene once reached a deadlock...